SCHEMBL1012919

SCHEMBL1012919

COc1cc2c(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)ncnc2cc1OCCCN1CCSC(=O)C1=O

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.76
RAF1 P04049 16/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1012725 1.00 BRAF (0.76) BRAFRAF1
SCHEMBL1012599 0.97 BRAF (0.76) BRAFRAF1
SCHEMBL17911693 0.89 BRAF (0.89) BRAFRAF1
SCHEMBL19258208 0.87 BRAF (0.99) BRAFRAF1
SCHEMBL1013737 0.87 BRAF (1.00) BRAFRAF1
SCHEMBL1011954 0.87 BRAF (1.00) BRAFRAF1
SCHEMBL1013022 0.87 BRAF (1.00) BRAFRAF1
SCHEMBL1012290 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1013251 0.86 RAF1 (1.00) BRAFRAF1
SCHEMBL1012063 0.86 BRAF (1.00) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed